{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:56:17Z","timestamp":1790916977533,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1245\/s10434-026-20135-z","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:30:15Z","timestamp":1783513815000},"page":"9678-9685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lymphovascular Invasion in SOUND-Eligible Breast Cancer: Implications for Occult Axillary Nodal Metastasis"],"prefix":"10.1245","volume":"33","author":[{"given":"Thomas","family":"Amburn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Sporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likolani","family":"Arthurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Acacia","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"DiMaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Axelrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freya","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L.","family":"Gemignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"25","key":"20135_CR1","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","volume":"385","author":"K Kalinsky","year":"2021","unstructured":"Kalinsky K, Barlow WE, Gralow JR, et al. 21-Gene assay to inform chemotherapy benefit in node-positive breast cancer. N Engl J Med. 2021;385(25):2336\u201347.","journal-title":"N Engl J Med."},{"key":"20135_CR2","doi-asserted-by":"publisher","first-page":"105186","DOI":"10.1016\/j.ebiom.2024.105186","volume":"105","author":"H Li","year":"2024","unstructured":"Li H, Zhao Y, Huang Y, et al. Clinical efficacy of CDK4\/6 inhibitor plus endocrine therapy in HR-positive\/HER2-0 and HER2-low-positive metastatic breast cancer: a secondary analysis of PALOMA-2 and PALOMA-3 trials. EBioMedicine. 2024;105:105186.","journal-title":"EBioMedicine."},{"issue":"11","key":"20135_CR3","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","volume":"9","author":"OD Gentilini","year":"2023","unstructured":"Gentilini OD, Botteri E, Sangalli C, et al. Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial. JAMA Oncol. 2023;9(11):1557\u201364.","journal-title":"JAMA Oncol."},{"issue":"11","key":"20135_CR4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","volume":"392","author":"T Reimer","year":"2025","unstructured":"Reimer T, Stachs A, Veselinovic K, et al. Axillary surgery in breast cancer\u2014Primary results of the INSEMA trial. N Engl J Med. 2025;392(11):1051\u201364.","journal-title":"N Engl J Med."},{"issue":"1","key":"20135_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12885-017-3443-x","volume":"17","author":"LM van Roozendaal","year":"2017","unstructured":"van Roozendaal LM, de Wilt JH, van Dalen T, et al. Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013\u201308). BMC Cancer. 2017;17(1):459.","journal-title":"BMC Cancer."},{"issue":"1","key":"20135_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00000478-197701010-00003","volume":"1","author":"FA Nime","year":"1977","unstructured":"Nime FA, Rosen PP, Thaler HT, et al. Prognostic significance of tumor emboli in intramammary lymphatics in patients with mammary carcinoma. Am J Surg Pathol. 1977;1(1):25\u201330.","journal-title":"Am J Surg Pathol."},{"issue":"1","key":"20135_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1365-2559.1994.tb01269.x","volume":"24","author":"SE Pinder","year":"1994","unstructured":"Pinder SE, Ellis IO, Galea M, et al. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology. 1994;24(1):41\u20137.","journal-title":"Histopathology."},{"issue":"10","key":"20135_CR8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/jnci\/djp090","volume":"101","author":"B Ejlertsen","year":"2009","unstructured":"Ejlertsen B, Jensen MB, Rank F, et al. Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer. J Natl Cancer Inst. 2009;101(10):729\u201335.","journal-title":"J Natl Cancer Inst."},{"issue":"1","key":"20135_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/1097-0142(197507)36:1<1::AID-CNCR2820360102>3.0.CO;2-4","volume":"36","author":"ER Fisher","year":"1975","unstructured":"Fisher ER, Gregorio RM, Fisher B, et al. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer. 1975;36(1):1\u201385.","journal-title":"Cancer"},{"issue":"5","key":"20135_CR10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1097\/00000658-199911000-00012","volume":"230","author":"C Gajdos","year":"1999","unstructured":"Gajdos C, Tartter PI, Bleiweiss IJ. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers. Ann Surg. 1999;230(5):692\u20136.","journal-title":"Ann Surg."},{"issue":"6","key":"20135_CR11","doi-asserted-by":"publisher","first-page":"100316","DOI":"10.1016\/j.esmoop.2021.100316","volume":"6","author":"G Houvenaeghel","year":"2021","unstructured":"Houvenaeghel G, Cohen M, Classe JM, et al. Lymphovascular invasion has a significant prognostic impact in patients with early breast cancer, results from a large, national, multicenter, retrospective cohort study. ESMO Open. 2021;6(6):100316.","journal-title":"ESMO Open."},{"issue":"Suppl 6","key":"20135_CR12","doi-asserted-by":"publisher","first-page":"vi7","DOI":"10.1093\/annonc\/mdt284","volume":"24","author":"E Senkus","year":"2013","unstructured":"Senkus E, Kyriakides S, Penault-Llorca F, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi7-23.","journal-title":"Ann Oncol."},{"issue":"2","key":"20135_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.prro.2023.11.001","volume":"14","author":"SF Shaitelman","year":"2024","unstructured":"Shaitelman SF, Anderson BM, Arthur DW, et al. Partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ: an ASTRO clinical practice guideline. Pract Radiat Oncol. 2024;14(2):112\u201332.","journal-title":"Pract Radiat Oncol."},{"issue":"3","key":"20135_CR14","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3390\/biomedicines11030968","volume":"11","author":"E Kuhn","year":"2023","unstructured":"Kuhn E, Gambini D, Despini L, et al. Updates on lymphovascular invasion in breast cancer. Biomedicines. 2023;11(3):968.","journal-title":"Biomedicines."},{"issue":"10","key":"20135_CR15","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.5858\/133.10.1515","volume":"133","author":"SC Lester","year":"2009","unstructured":"Lester SC, Bose S, Chen YY, et al. Protocol for the examination of specimens from patients with invasive carcinoma of the breast. Arch Pathol Lab Med. 2009;133(10):1515\u201338.","journal-title":"Arch Pathol Lab Med."},{"issue":"11","key":"20135_CR16","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1038\/sj.bjc.6603152","volume":"94","author":"GG Van den Eynden","year":"2006","unstructured":"Van den Eynden GG, Van der Auwera I, Van Laere SJ, et al. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study. Br J Cancer. 2006;94(11):1643\u20139.","journal-title":"Br J Cancer."},{"key":"20135_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1200\/CCI.20.00104","volume":"5","author":"VF Torous","year":"2021","unstructured":"Torous VF, Simpson RW, Balani JP, et al. College of American Pathologists Cancer Protocols: from optimizing cancer patient care to facilitating interoperable reporting and downstream data use. JCO Clin Cancer Inform. 2021;5:47\u201355.","journal-title":"JCO Clin Cancer Inform."},{"issue":"10","key":"20135_CR18","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1093\/annonc\/mdm268","volume":"18","author":"M Colleoni","year":"2007","unstructured":"Colleoni M, Rotmensz N, Maisonneuve P, et al. Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol. 2007;18(10):1632\u201340.","journal-title":"Ann Oncol."},{"key":"20135_CR19","doi-asserted-by":"publisher","first-page":"1269971","DOI":"10.3389\/fonc.2023.1269971","volume":"13","author":"SJ Lee","year":"2023","unstructured":"Lee SJ, Go J, Ahn BS, et al. Lymphovascular invasion is an independent prognostic factor in breast cancer irrespective of axillary node metastasis and molecular subtypes. Front Oncol. 2023;13:1269971.","journal-title":"Front Oncol."},{"issue":"2","key":"20135_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0046-8177(82)80121-4","volume":"13","author":"KW Gilchrist","year":"1982","unstructured":"Gilchrist KW, Gould VE, Hirschl S, et al. Interobserver variation in the identification of breast carcinoma in intramammary lymphatics. Hum Pathol. 1982;13(2):170\u20132.","journal-title":"Hum Pathol."},{"issue":"1","key":"20135_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijrobp.2004.04.065","volume":"61","author":"J Reznik","year":"2005","unstructured":"Reznik J, Cicchetti MG, Degaspe B, Fitzgerald TJ. Analysis of axillary coverage during tangential radiation therapy to the breast. Int J Radiat Oncol Biol Phys. 2005;61(1):163\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.04.065.","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"5","key":"20135_CR22","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/jrr\/rrv035","volume":"56","author":"K Wadasaki","year":"2015","unstructured":"Wadasaki K, Nishibuchi I. Relationship between sentinel lymph nodes and postoperative tangential fields in early breast cancer, evaluated using SPECT\/CT. J Radiat Res. 2015;56(5):835\u201340. https:\/\/doi.org\/10.1093\/jrr\/rrv035.","journal-title":"J Radiat Res."},{"issue":"10","key":"20135_CR23","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918\u201326. https:\/\/doi.org\/10.1001\/jama.2017.11470.","journal-title":"JAMA."},{"issue":"12","key":"20135_CR24","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15(12):1303\u201310. https:\/\/doi.org\/10.1016\/S1470-2045(14)70460-7.","journal-title":"Lancet Oncol."},{"issue":"18","key":"20135_CR25","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa2412225","volume":"393","author":"IH Kunkler","year":"2025","unstructured":"Kunkler IH, Russell NS, Anderson N, et al. Ten-year survival after postmastectomy chest-wall irradiation in breast cancer. N Engl J Med. 2025;393(18):1771\u201383. https:\/\/doi.org\/10.1056\/NEJMoa2412225.","journal-title":"N Engl J Med."},{"issue":"2","key":"20135_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.5603\/RPOR.a2022.0037","volume":"27","author":"J Lenihan","year":"2022","unstructured":"Lenihan J, Rangaswamy G, Faul C. The role of radiotherapy in the management of nodal disease in breast cancer. Rep Pract Oncol Radiother. 2022;27(2):331\u201343. https:\/\/doi.org\/10.5603\/RPOR.a2022.0037.","journal-title":"Rep Pract Oncol Radiother."},{"issue":"3","key":"20135_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ejca.2005.10.021","volume":"42","author":"AH Lee","year":"2006","unstructured":"Lee AH, Pinder SE, Macmillan RD, et al. Prognostic value of lymphovascular invasion in women with lymph node\u2013negative invasive breast carcinoma. Eur J Cancer. 2006;42(3):357\u201362. https:\/\/doi.org\/10.1016\/j.ejca.2005.10.021.","journal-title":"Eur J Cancer."},{"issue":"3","key":"20135_CR28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10549-016-3837-5","volume":"157","author":"YL Liu","year":"2016","unstructured":"Liu YL, Saraf A, Lee SM, et al. Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy. Breast Cancer Res Treat. 2016;157(3):555\u201364.","journal-title":"Breast Cancer Res Treat."},{"issue":"30","key":"20135_CR29","doi-asserted-by":"publisher","first-page":"e11647","DOI":"10.1097\/MD.0000000000011647","volume":"97","author":"YJ Ryu","year":"2018","unstructured":"Ryu YJ, Kang SJ, Cho JS, et al. Lymphovascular invasion can be better than pathologic complete response to predict prognosis in breast cancer treated with neoadjuvant chemotherapy. Med (Baltim). 2018;97(30):e11647.","journal-title":"Med (Baltim)."},{"issue":"12","key":"20135_CR30","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1056\/NEJMoa2305488","volume":"390","author":"D Slamon","year":"2024","unstructured":"Slamon D, Lipatov O, Nowecki Z, et al. Ribociclib plus endocrine therapy in early breast cancer. N Engl J Med. 2024;390(12):1080\u201391. https:\/\/doi.org\/10.1056\/NEJMoa2305488.","journal-title":"N Engl J Med."},{"issue":"10","key":"20135_CR31","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3390\/jpm13101476","volume":"13","author":"C Kay","year":"2023","unstructured":"Kay C, Martinez-Perez C, Dixon JM, Turnbull AK. The role of nodes and nodal assessment in diagnosis, treatment and prediction in ER+, node-positive breast cancer. J Pers Med. 2023;13(10):1476. https:\/\/doi.org\/10.3390\/jpm13101476.","journal-title":"J Pers Med."},{"key":"20135_CR32","doi-asserted-by":"publisher","unstructured":"Kandzi JD, Englisch A, Boeer B, et al. Reconciling sentinel node omission with CDK4\/6 inhibitor eligibility in HR+\/HER2- early breast cancer: a real-world cohort analysis.\u00a0Clin Breast Cancer.\u00a0Published online October 13, 2025. https:\/\/doi.org\/10.1016\/j.clbc.2025.10.003.","DOI":"10.1016\/j.clbc.2025.10.003"},{"issue":"5","key":"20135_CR33","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1200\/JCO.18.01160","volume":"37","author":"HJ Burstein","year":"2019","unstructured":"Burstein HJ, Lacchetti C, Anderson H, et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol. 2019;37(5):423\u201338. https:\/\/doi.org\/10.1200\/JCO.18.01160.","journal-title":"J Clin Oncol."},{"issue":"3","key":"20135_CR34","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000477795","volume":"12","author":"I Sestak","year":"2017","unstructured":"Sestak I. Identifying biomarkers to select patients with early breast cancer suitable for extended adjuvant endocrine therapy. Breast Care (Basel). 2017;12(3):146\u201351. https:\/\/doi.org\/10.1159\/000477795.","journal-title":"Breast Care (Basel)."},{"issue":"10503","key":"20135_CR35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0140-6736(25)01013-X","volume":"406","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2025","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG). Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomized trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy. Lancet. 2025;406(10503):603\u201314. https:\/\/doi.org\/10.1016\/S0140-6736(25)01013-X.","journal-title":"Lancet."},{"issue":"1","key":"20135_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s004280050297","volume":"434","author":"JP Sloane","year":"1999","unstructured":"Sloane JP, Amendoeira I, Apostolikas N, et al. Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology. Virchows Arch. 1999;434(1):3\u201310.","journal-title":"Virchows Arch."},{"issue":"15","key":"20135_CR37","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/cncr.26711","volume":"118","author":"EA Rakha","year":"2012","unstructured":"Rakha EA, Martin S, Lee AHS, et al. The prognostic significance of lymphovascular invasion in invasive breast carcinoma. Cancer. 2012;118(15):3670\u201380.","journal-title":"Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20135-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20135-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20135-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:51:13Z","timestamp":1790916673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-20135-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["20135"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20135-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}